idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
Aiming to bridge the gap between cutting-edge biomedical research and real-world clinical application, the Berlin Institute of Health at Charité (BIH) entered into an agreement with BioLabs, an internationally known innovation laboratory platform with a network of shared lab and office workspaces, to support operations at the full-service BIH Clinical Incubator (CLIC). The incubator is designed to foster novel advanced therapies for patients and support entrepreneurship in the field of regenerative medicine.
CLIC will be a fully-equipped combination of office and laboratory facility dedicated to supporting scientists and entrepreneurial founders in the development of healthcare startups making advanced therapeutics a reality. CLIC will provide the tools, expertise, and collaborative space needed to drive the next generation of personalized medical solutions, particularly in Advanced Therapy Medicinal Products (ATMPs). By combining scientific rigor with entrepreneurial and regulatory guidance, CLIC ensures that academic researchers, clinicians, and startup founders can transform promising innovations into therapies that have a tangible impact on patient care.
“CLIC serves as a launchpad for life science entrepreneurs and researchers aiming to translate groundbreaking therapies from concept to clinic and I’m thrilled to bring the incubator to Berlin's dynamic research and healthcare landscape. Having been part of Boston’s vibrant life sciences ecosystem, I’ve seen firsthand how the right environment can foster groundbreaking innovations”, said Dr. Garima Bhardwaj, Head of the Clinical Incubator . “Berlin offers a unique environment to build an entrepreneurial community that bridges cutting-edge science with real-world applications, driving forward transformational therapies for patients across the globe.”
A unique support structure for life science startups
Together with BioLabs, the BIH will offer a comprehensive support structure spanning state-of-the-art facilities, business development services, operational funding, mentorship, access to venture capital, and industry partnerships. The spaces will be located on the campus of Charité – Universitätsmedizin Berlin, one of Europe’s largest university hospitals. The facilities are designed to meet the needs of entrepreneurs, early-stage startups, and academic research teams that are focused on pioneering new treatments.
The CLIC program is already open for applications and will start operations on July 15 this year. More details about the application process can be found here: https://lf5da1tbxim.typeform.com/to/wri284qG?typeform-source=euc-word-edit.offic....
“We identified the key bottlenecks to bring advanced therapies to patients and here CLIC helps everyone seeking a place to launch advanced and personalized technologies and provides a clinical de-risking environment”, said Prof. Dr. Georg Duda, Director of the Julius Wolff Institute and Speaker of the BIH Center for Regenerative Therapies (BCRT). "The BCRT has a long-standing tradition of successfully bringing innovative therapies into clinical trials. We’re looking forward to opening this opportunity to the wider life science community in Berlin and beyond.”
“Working with the experienced teams at the BIH and Charité is an extraordinary opportunity”, said BioLabs founder and CEO Johannes Fruehauf. “We are proud to contribute in this creation of state-of-the-art facilities for scientists and entrepreneurs in Berlin. Like all our sites, the CLIC is designed to stimulate creative interaction and collaboration while offering access to BIH and Charité's world-class scientific capabilities.”
In addition to the facilities, the program will offer access to leading experts at the BIH and Charité and beyond.
“Biomedical translation can only succeed in a strong ecosystem and CLIC is an essential addition to ours. We’re very happy that we can enable and support even more life science entrepreneurs and researchers to translate scientific findings into actual therapies and thus impact people’s health”, said Prof. Dr. Christopher Baum, Chairman of the Board of Directors of the BIH at Charité and Chief Translational Research Officer of Charité – Universitätsmedizin Berlin. “CLIC will also make a strong contribution to our fruitful collaborations with other national and international biomedical translation hubs.”
https://www.bihealth.org/en/notices/bih-partners-with-biolabs-to-launch-clinical...
http://Find out more on the CLIC webpage:
https://www.bihealth.org/en/research/scientific-infrastructure/bih-clinical-incu...
http://The CLIC program is already open for applications and will start operations on July 15 this year. More details about the application process can be found here: https://lf5da1tbxim.typeform.com/to/wri284qG?typeform-source=euc-word-edit.offic....
The Team of the BIH Clinical Incubator
Sabine Gudath
© BIH | Sabine Gudath
Merkmale dieser Pressemitteilung:
Journalisten
Biologie, Medizin
überregional
Forschungs- / Wissenstransfer, Forschungsprojekte
Englisch
The Team of the BIH Clinical Incubator
Sabine Gudath
© BIH | Sabine Gudath
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
